Market revenue in 2023 | USD 707.2 million |
Market revenue in 2030 | USD 868.0 million |
Growth rate | 3% (CAGR from 2023 to 2030) |
Largest segment | Hospitals |
Fastest growing segment | Outpatient Facilities |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, OSYPKA MEDICAL, Integer Holdings Corp, Danaher Corp, Abbott Laboratories, Avery Dennison Corp, BIOTRONIK, Lepu Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to external pacemakers market will help companies and investors design strategic landscapes.
Hospitals was the largest segment with a revenue share of 73.59% in 2023. Horizon Databook has segmented the North America external pacemakers market based on hospitals, outpatient facilities covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America external pacemakers market , including forecasts for subscribers. This continent databook contains high-level insights into North America external pacemakers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account